Cardlytics (CDLX) Tops Q4 EPS by 47c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall St declines as oil spikes after Trump rejects Iran peace proposal
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
- Bloom Energy shares fall on Oracle project halt
- Oppenheimer sees AI software winners as focus shifts to ROI
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
- Arm Holdings falls as CFO stock sale weighs on sentiment
Cardlytics (CDLX) PT Lowered to $3 at Evercore ISI
March 13, 2025 10:02 AM EDTEvercore ISI analyst Mark Mahaney lowered the price target on Cardlytics (NASDAQ: CDLX) to $3.00 (from $4.00) while maintaining a In Line rating.
The analyst comments "Our View: We maintain our In Line rating but lower our price target to $3 (from $4... More
Cardlytics (CDLX) PT Lowered to $2.50 at BofA Securities
March 13, 2025 6:50 AM EDTBofA Securities analyst Omar Dessouky lowered the price target on Cardlytics (NASDAQ: CDLX) to $2.50 (from $4.00) while maintaining a Underperform rating.
The analyst comments "4Q Revenue/Adj. Contribution ($74mn/$41mn) both landed above the high end of guidance ($67mn/$36mn), with EBITDA also... More
